Keebeck Wealth Management’s Transcat TRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,432
Closed -$1.31M 294
2024
Q4
$1.31M Sell
12,432
-79
-0.6% -$8.77K 0.19% 114
2024
Q3
$1.51M Sell
12,511
-551
-4% -$68.5K 0.22% 106
2024
Q2
$1.56M Sell
13,062
-4,339
-25% -$512K 0.23% 110
2024
Q1
$1.94M Buy
17,401
+1,606
+10% +$170K 0.29% 96
2023
Q4
$1.73M Buy
15,795
+3,303
+26% +$318K 0.28% 98
2023
Q3
$1.22M Buy
12,492
+2,523
+25% +$241K 0.21% 109
2023
Q2
$850K Buy
9,969
+5,551
+126% +$473K 0.12% 137
2023
Q1
$395K Buy
+4,418
New +$376K 0.06% 181

Other funds holding TRNS

Keebeck Wealth Management's TRNS Position: Q1 2025 in Review

Keebeck Wealth Management sold out of Transcat (TRNS) in Q1 2025, closing a stake of 12,432 shares — an estimated $1.31M sold.

Keebeck Wealth Management first reported a position in TRNS in Q1 2023 and held it in 8 quarters. The position peaked at $1.94M in Q1 2024. 135 funds tracked by Wall St. Rank hold TRNS as of Q1 2025.

  • Keebeck Wealth Management reported no remaining Transcat position as of Q1 2025 after selling out during the quarter.
  • Keebeck Wealth Management sold 12,432 Transcat shares in Q1 2025, an estimated $1.31M.
  • Keebeck Wealth Management first reported a position in Transcat in Q1 2023 and held it in 8 quarters.
  • Keebeck Wealth Management's Transcat position peaked at $1.94M in Q1 2024.
  • 135 funds tracked by Wall St. Rank held Transcat as of Q1 2025.

Based on Keebeck Wealth Management's 13F filing for Q1 2025, filed 15 May 2025.